Stock 3692 HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Hansoh Pharmaceutical Group Company Limited

Equities

3692

KYG549581067

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:16 2024-04-24 am EDT 		5-day change 1st Jan Change
16.8 HKD +2.82% Intraday chart for Hansoh Pharmaceutical Group Company Limited +6.60% +6.60%
Apr. 03 Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug MT
Apr. 03 Hansoh Pharmaceutical Group Company Limited, Jiangsu Hansoh Pharmaceutical Group Company Limited and Shanghai Hansoh Biomedical Technology Company Limited Receives Grant of A Clinical Trial Notice Issued by the National Medical Products Administration of the People's Republic of China to Be Used for the Treatment of Advanced Non-Small Cell Lung Cancer CI

Business Summary

Hansoh Pharmaceutical Group Company Limited specializes in the development, manufacture and marketing of pharmaceutical products for the treatment of tumor, infectious, metabolic and autoimmune diseases. Net sales break down by revenue source as follows:

- sales of pharmaceutical products (99.1%);

- sales of research and development services (0.9%).

Number of employees: 9,123

Sales per Business

HKD in Million2021Weight2022Weight Delta
Anti-tumor
58.9 %
6,606 55.2 % 6,421 58.9 % -2.79%
Central Nervous System
15.9 %
2,022 16.9 % 1,737 15.9 % -14.09%
Anti-infective
13.3 %
1,811 15.1 % 1,452 13.3 % -19.82%
Metabolism and Other Main Therapeutic Products
11.9 %
1,534 12.8 % 1,299 11.9 % -15.34%

Sales per region

HKD in Million2021Weight2022Weight Delta
China
100.0 %
11,974 100.0 % 10,911 100.0 % -8.88%

Managers

Managers TitleAgeSince
Hui Juan Zhong CEO
 Chief Executive Officer 63 15-12-01
Sheng Li Zhong SEC
 Corporate Secretary 56 -
Yan Wing Li SEC
 Corporate Secretary 58 -

Members of the board

Members of the board TitleAgeSince
Guo Qiang Lin BRD
 Director/Board Member 81 19-05-30
Sheung Wai Chan BRD
 Director/Board Member 70 19-06-13
Dong Tao Yang BRD
 Director/Board Member 67 -
Hui Juan Zhong CEO
 Chief Executive Officer 63 15-12-01
Ai Feng Lyu BRD
 Director/Board Member 47 16-03-10
Yu An Sun BRD
 Director/Board Member 38 15-12-01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,933,350,070 1,084,286,470 ( 18.27 %) 0 18.27 %

Shareholders

NameEquities%Valuation
Yu An Sun
65.74 %
3,900,408,100 65.74 % 7 715 M $
Jun Da Cen
16.01 %
950,000,000 16.01 % 1 879 M $
UBS Asset Management (Hong Kong) Ltd.
0.4599 %
27,287,481 0.4599 % 54 M $
Fidelity Management & Research (Hong Kong) Ltd.
0.4496 %
26,674,000 0.4496 % 53 M $
Bosera Asset Management Co., Ltd.
0.1556 %
9,234,000 0.1556 % 18 M $
Zhong Geng Fund Management Co. , Ltd.
0.1131 %
6,712,000 0.1131 % 13 M $
China Asset Management Co., Ltd.
0.0859 %
5,094,000 0.0859 % 10 M $
Pictet Asset Management (Hong Kong) Ltd.
0.0623 %
3,696,000 0.0623 % 7 M $
Euromobiliare Asset Management SGR SpA
0.0441 %
2,616,000 0.0441 % 5 M $
Sjunde AP-fonden
0.0423 %
2,508,000 0.0423 % 5 M $

Company contact information

Hansoh Pharmaceutical Group Co., Ltd.

287 Xiangke Road Pudong New District

201210, Shanghai

+

http://www.hspharm.com
address Hansoh Pharmaceutical Group Company Limited(3692)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Hansoh Pharmaceutical Group Company Limited

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
15.54 CNY
Average target price
17.47 CNY
Spread / Average Target
+12.38%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED Stock Hansoh Pharmaceutical Group Company Limited
+6.60% 12.35B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.61% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.87% 570B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.24% 360B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.49% 321B
ABBVIE INC. Stock AbbVie Inc.
+8.28% 300B
ASTRAZENECA PLC Stock AstraZeneca PLC
+7.09% 217B
ROCHE HOLDING AG Stock Roche Holding AG
-9.12% 204B
NOVARTIS AG Stock Novartis AG
+5.01% 199B
PFIZER, INC. Stock Pfizer, Inc.
-8.75% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 3692 Stock
  4. Company Hansoh Pharmaceutical Group Company Limited